Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma: beyond the context of a clinical trial

K.L. Wu, W.N. van Wieringen, E. Vellenga, S. Zweegman, W.M. Smit, H.M. Lokhorst, P. Sonneveld

    Research output: Contribution to JournalArticleAcademicpeer-review

    20 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)996-997
    JournalHaematologica
    Volume90
    Publication statusPublished - 2005

    Cite this